NCT06268665View on ClinicalTrials.gov

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

PHASE2RecruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

August 15, 2024

Primary Completion Date

October 31, 2027

Study Completion Date

December 31, 2027

Conditions
Breast CancerBreast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage IIIBreast Cancer Stage IVInvasive Breast CancerOvarian CancerOvarian Cancer Stage 1Ovarian Cancer Stage IIOvarian Cancer Stage IIIOvarian Cancer Stage IVOvarian Cancer Stage IAOvarian Cancer Stage IBOvarian Cancer Stage ICOvarian Cancer Stage 2Ovarian Cancer Stage 3Ovarian Cancer Stage IIIbOvarian Cancer Stage IIICBreast Cancer Stage IIIABreast Cancer InvasiveBreast Cancer, Stage IABreast Cancer, Stage IBBreast Cancer Stage IIABreast Cancer Stage IIBBreast Cancer Stage IIIBBreast Cancer Stage IIIcCancer, BreastTumors, BreastMammary CancerMammary CarcinomaBreast CarcinomaBreast NeoplasmMalignant Breast NeoplasmMalignant Tumor of BreastCancer of OvaryOvary CancerOvary Neoplasm
Interventions
DRUG

Tart Cherry Juice

Given PO

Trial Locations (1)

95827

RECRUITING

University of California Davis Comprehensive Cancer Center, Sacramento

All Listed Sponsors
lead

Eve Rodler

OTHER